Fora Capital, LLC Sage Therapeutics, Inc. Transaction History

Fora Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$70.65 - $96.76 $252,361 - $345,626	-3,572 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$58.41 - $89.06 $208,640 - $318,122	3,572 New	3,572 $309,000
Q3 2020 Nov 13, 2020	SELL	$41.13 - $62.45 $216,672 - $328,986	-5,268 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$25.95 - $43.15 $130,969 - $217,778	-5,047 Reduced 48.93%	5,268 $219 Million
Q1 2020 May 15, 2020	BUY	$26.15 - $77.24 $269,737 - $796,730	10,315 New	10,315 $296,000

198

46.5M

402K

209K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $333M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Fora Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Fora Capital, LLC with notifications on news.